Cell therapies represent a groundbreaking advancement in healthcare for patients with chronic diseases. Such therapies involve implanting living cells in order to repair or replace damaged tissues, allowing the body to self-heal. Cell therapy thus addresses the root cause of disease, whereas conventional treatments focus largely on managing symptoms. Vanessa LaPointe specialises in cell therapies for vision-threatening conditions affecting the cornea and ocular surface. She conducts research across the entire bench-to-bedside spectrum, from uncovering new scientific insights to developing innovative therapies.